Carboplatin Dose Calculator (Calvert)
Calculate Carboplatin Dose Using AUC
0 mL/min
No
5
Note: GFR is capped at 125 mL/min per FDA recommendations to prevent overdosing.
| Creatinine (mg/dL) | Est. GFR (mL/min) | Calc. Dose (mg) |
|---|
Table of Contents
What is Calculate Carboplatin Dose Using AUC?
To calculate carboplatin dose using AUC is to utilize the Calvert Formula, a standard oncological method for determining the appropriate chemotherapy dosage for a patient. Unlike many other chemotherapy drugs that are dosed based on Body Surface Area (BSA), Carboplatin is dosed based on renal function and a target Area Under the Curve (AUC).
The goal of this calculation is to achieve a specific therapeutic drug exposure (the AUC) while minimizing toxicity, specifically thrombocytopenia (low platelet count). Because Carboplatin is primarily excreted by the kidneys, the patient’s Glomerular Filtration Rate (GFR) is the single most critical variable in this equation.
Oncologists, pharmacists, and infusion nurses use this calculation daily to ensure patient safety. It is particularly important for patients with compromised renal function or elderly patients where standard dosing might lead to severe toxicity.
The Calvert Formula and Mathematical Explanation
The mathematical foundation used to calculate carboplatin dose using AUC is known as the Calvert Formula. It was developed to provide a predictable drug exposure regardless of the patient’s size or weight, focusing instead on how quickly their body can clear the drug.
Total Dose (mg) = Target AUC × (GFR + 25)
Where:
- Target AUC: The desired Area Under the concentration-time Curve (mg·min/mL).
- GFR: Glomerular Filtration Rate (mL/min), usually estimated via the Cockcroft-Gault equation using serum creatinine.
- 25: A constant representing non-renal clearance of the drug.
| Variable | Meaning | Unit | Typical Range |
|---|---|---|---|
| Dose | Total Carboplatin Amount | Milligrams (mg) | 300 – 900 mg |
| AUC | Drug Exposure Target | mg·min/mL | 4 – 7 |
| GFR (CrCl) | Kidney Filtration Rate | mL/min | 20 – 125+ |
| Creatinine | Kidney Waste Marker | mg/dL | 0.5 – 2.0 |
Practical Examples (Real-World Use Cases)
Here are two scenarios illustrating how to calculate carboplatin dose using AUC in a clinical setting.
Example 1: Standard Patient
- Patient: 65-year-old Male
- Weight: 75 kg
- Serum Creatinine: 0.9 mg/dL
- Target AUC: 5
Step 1: Calculate GFR (Cockcroft-Gault)
GFR = ((140 – 65) × 75) / (72 × 0.9) = 5625 / 64.8 = 86.8 mL/min
Step 2: Apply Calvert Formula
Dose = 5 × (86.8 + 25) = 5 × 111.8 = 559 mg
Example 2: Patient with High GFR (The “Cap” Rule)
- Patient: 30-year-old Male
- Weight: 90 kg
- Serum Creatinine: 0.7 mg/dL
- Target AUC: 6
Step 1: Calculate Raw GFR
GFR = ((140 – 30) × 90) / (72 × 0.7) = 9900 / 50.4 = 196.4 mL/min
Step 2: Apply FDA Cap
Since 196.4 > 125, we cap the GFR at 125 mL/min.
Step 3: Apply Calvert Formula
Dose = 6 × (125 + 25) = 6 × 150 = 900 mg
Without the cap, the dose would have been 1328 mg, potentially causing lethal toxicity.
How to Use This Carboplatin Calculator
- Enter Target AUC: Select the protocol-defined AUC (usually 5 or 6).
- Input Serum Creatinine: Enter the patient’s most recent lab result in mg/dL. Ensure the value is stable.
- Enter Patient Demographics: Input accurate age, weight (kg), and biological sex. These are crucial for the GFR estimation.
- Review Results: The tool will instantly calculate carboplatin dose using AUC.
- Check Intermediate Values: Verify the estimated GFR looks correct for the patient’s clinical picture.
- Copy or Reset: Use the buttons to copy the data for documentation or reset for the next patient.
Key Factors That Affect Carboplatin Dose Results
When you calculate carboplatin dose using AUC, several physiological and external factors influence the final number:
- Renal Function (Creatinine): This is the most sensitive variable. A small increase in serum creatinine (indicating worse kidney function) significantly lowers the calculated GFR and thus the final dose.
- Age: As patients age, their natural GFR declines. Even with normal creatinine levels, an elderly patient will require a lower dose than a younger patient of the same weight.
- Weight and Obesity: In obese patients, using actual body weight in the Cockcroft-Gault formula can overestimate GFR. Many institutions use Adjusted Body Weight (AdjBW) for patients with a BMI > 25 or 30.
- Target AUC Selection: The AUC is chosen based on the treatment intent (curative vs. palliative), combination with other drugs, and patient tolerance. A higher AUC (e.g., 7) increases cell kill but raises toxicity risk.
- Gender: Females have generally lower muscle mass than males, leading to lower creatinine generation. The formula multiplies the result by 0.85 for females to account for this.
- GFR Capping: Regulatory bodies (like the FDA and EMA) recommend capping the GFR at 125 mL/min to avoid overdosing patients with low creatinine levels or high muscle mass.
Frequently Asked Questions (FAQ)
Carboplatin elimination is almost entirely dependent on kidney filtration. BSA does not correlate well with renal function. Using AUC provides a more predictable toxicity profile compared to BSA dosing.
Generally, the dose is capped based on a maximum GFR of 125 mL/min. For a target AUC of 6, the max dose is typically 6 × (125 + 25) = 900 mg. Always verify protocol limits.
No. This tool uses the Cockcroft-Gault equation which is validated for adults (18+). Pediatric dosing typically requires the Schwartz formula or nuclear GFR methods.
Low creatinine (e.g., < 0.7 mg/dL) often occurs in elderly or cachectic patients with low muscle mass. This can falsely elevate the estimated GFR. Some clinicians round creatinine up to 0.7 or 0.8 mg/dL to prevent overdosing, though this practice varies by institution.
This calculator accepts mg/dL. If you have µmol/L, divide by 88.4 to convert to mg/dL before entering.
The constant 25 represents the non-renal clearance of Carboplatin (approximately 25 mL/min), accounting for the drug cleared by other bodily tissues.
There is debate. Most standard guidelines suggest using Actual Body Weight, but capping the GFR at 125 mL/min acts as a safeguard against obesity-related overestimation.
The dose should be recalculated before every cycle, especially if the patient’s weight changes significantly or if serum creatinine levels fluctuate.
Related Tools and Internal Resources